• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

Introduction to 1H-Benzimidazole-2-acetonitrile,6-fluoro (CAS No. 115201-20-2)

1H-Benzimidazole-2-acetonitrile,6-fluoro, identified by its Chemical Abstracts Service (CAS) number 115201-20-2, is a fluorinated benzimidazole derivative that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to a class of heterocyclic molecules known for their diverse biological activities and potential therapeutic applications. The structural features of 1H-Benzimidazole-2-acetonitrile,6-fluoro, particularly the presence of a nitrile group at the 2-position and a fluorine atom at the 6-position, contribute to its unique chemical properties and biological interactions.

The benzimidazole core is a well-established scaffold in drug discovery, with numerous examples of benzimidazole-based compounds exhibiting antimicrobial, antiviral, anticancer, and anti-inflammatory properties. The introduction of fluorine at the 6-position of the benzimidazole ring is a common modification aimed at enhancing metabolic stability, improving binding affinity to biological targets, and modulating pharmacokinetic profiles. The nitrile group at the 2-position further extends the structural diversity of this compound, enabling various functionalization strategies and influencing its reactivity and biological activity.

In recent years, there has been growing interest in fluorinated benzimidazoles due to their potential as lead compounds in drug development. The fluorine atom can significantly affect the electronic properties of the molecule, leading to changes in its interaction with enzymes and receptors. This has made 1H-Benzimidazole-2-acetonitrile,6-fluoro a valuable building block for synthesizing novel therapeutic agents. For instance, studies have shown that fluorinated benzimidazoles can exhibit enhanced binding affinity to proteins involved in cancer pathways, making them promising candidates for targeted therapies.

One of the most compelling aspects of 1H-Benzimidazole-2-acetonitrile,6-fluoro is its versatility in medicinal chemistry. The nitrile group provides a site for further chemical modification, allowing researchers to explore different derivatives with tailored biological activities. Additionally, the presence of fluorine enhances the compound's lipophilicity and bioavailability, which are critical factors in drug design. These properties make it an attractive candidate for further investigation in preclinical and clinical studies.

Recent research has highlighted the potential of 1H-Benzimidazole-2-acetonitrile,6-fluoro in addressing unmet medical needs. For example, studies have demonstrated its efficacy in inhibiting specific enzymes implicated in inflammatory diseases. The compound's ability to modulate these enzymatic pathways suggests that it could be developed into a novel therapeutic agent for conditions such as rheumatoid arthritis and inflammatory bowel disease. Furthermore, preliminary data indicate that 1H-Benzimidazole-2-acetonitrile,6-fluoro may have applications in oncology, particularly in targeting pathways involved in tumor growth and progression.

The synthesis of 1H-Benzimidazole-2-acetonitrile,6-fluoro involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriately substituted benzoylacetonitriles and hydrazine derivatives, followed by fluorination at the desired position. Advanced techniques such as palladium-catalyzed cross-coupling reactions have also been employed to introduce fluorine atoms with high precision. These synthetic methodologies highlight the compound's importance as a key intermediate in pharmaceutical research.

The pharmacological profile of 1H-Benzimidazole-2-acetonitrile,6-fluoro is influenced by its structural features. The nitrile group can participate in hydrogen bonding interactions with biological targets, while the fluorine atom can influence electronic distributions across the molecule. These interactions are critical for determining the compound's binding affinity and selectivity. Computational modeling studies have been instrumental in understanding these interactions at a molecular level, providing insights into how modifications can enhance therapeutic efficacy.

In conclusion,1H-Benzimidazole-2-acetonitrile, particularly its 6-fluorinated derivative (CAS No. 115201-20-2), represents a promising scaffold for developing novel pharmaceutical agents. Its unique structural features offer opportunities for designing compounds with improved pharmacokinetic properties and enhanced biological activity. As research continues to uncover new therapeutic applications for fluorinated benzimidazoles,1H-Benzimidazole-2-acetonitrile,6-fluoro will likely remain at the forefront of medicinal chemistry innovation.

• 883541-03-5(3-(5-fluoro-1H-benzimidazol-2-yl)propan-1-amine)
• 29958-83-6(1H-Benzimidazole-2-carbonitrile,6-fluoro-)
• 177407-08-8(1-(5-Fluoro-1H-benzo[d]imidazol-2-yl)ethanamine)
• 109949-20-4(1H-Benzimidazole-2-ethanethiol,6-fluoro-)
• 118469-15-1(5-Fluoro-2-methyl-1H-benzodimidazole)
• 953071-94-8(1H-Benzimidazole, 7-fluoro-2-(1-methylethyl)-)
• 4414-88-4(2-(1H-benzimidazol-2-yl)acetonitrile)
• 78582-00-0(5,6-difluoro-2-(1-methylethyl)-1H-Benzimidazole)
• 146350-85-8(1H-Benzimidazole,2-butyl-6-fluoro-)
• 16405-80-4(6-Fluoro-2-(propan-2-yl)-1H-1,3-benzodiazole)